37.15
Newamsterdam Pharma Company Nv stock is traded at $37.15, with a volume of 2.79M.
It is up +0.27% in the last 24 hours and up +53.58% over the past month.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.
See More
Previous Close:
$37.05
Open:
$36.76
24h Volume:
2.79M
Relative Volume:
3.04
Market Cap:
$4.18B
Revenue:
$14.09M
Net Income/Loss:
$-176.94M
P/E Ratio:
-17.28
EPS:
-2.15
Net Cash Flow:
$-141.24M
1W Performance:
+14.38%
1M Performance:
+53.58%
6M Performance:
+145.70%
1Y Performance:
+104.23%
Newamsterdam Pharma Company Nv Stock (NAMS) Company Profile
Name
Newamsterdam Pharma Company Nv
Sector
Industry
Phone
35 206 2971
Address
GOOIMEER 2-35, NARRDEN
Compare NAMS with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
NAMS
Newamsterdam Pharma Company Nv
|
37.15 | 4.17B | 14.09M | -176.94M | -141.24M | -2.15 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Newamsterdam Pharma Company Nv Stock (NAMS) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Aug-25-25 | Initiated | Wells Fargo | Overweight |
Jul-17-25 | Initiated | Goldman | Neutral |
Jun-17-25 | Initiated | Citigroup | Buy |
Jun-10-25 | Initiated | Stifel | Buy |
Jun-04-25 | Initiated | Cantor Fitzgerald | Overweight |
Dec-30-24 | Initiated | H.C. Wainwright | Buy |
May-15-24 | Initiated | TD Cowen | Buy |
Mar-14-24 | Initiated | Scotiabank | Sector Outperform |
Jan-18-24 | Initiated | Guggenheim | Buy |
Jan-16-24 | Initiated | Piper Sandler | Overweight |
Oct-30-23 | Initiated | RBC Capital Mkts | Outperform |
View All
Newamsterdam Pharma Company Nv Stock (NAMS) Latest News
Technical analysis overview for NewAmsterdam Pharma Company N.V. Equity Warrant stockMarket Performance Summary & Accurate Trade Setup Notifications - newser.com
NewAmsterdam Pharma Company N.V. recovery potential after sell offM&A Rumor & Stock Portfolio Risk Control - newser.com
How to track smart money flows in NewAmsterdam Pharma Company N.V. Equity WarrantSwing Trade & Free Expert Verified Stock Movement Alerts - newser.com
Is it too late to sell NewAmsterdam Pharma Company N.V. Equity WarrantEarnings Beat & High Conviction Buy Zone Picks - newser.com
Will earnings trigger a reversal in NewAmsterdam Pharma Company N.V.Recession Risk & Fast Exit/Entry Strategy Plans - newser.com
Published on: 2025-10-13 07:22:45 - newser.com
Is NewAmsterdam Pharma Company N.V. stock a good choice for value investorsPortfolio Performance Report & Reliable Intraday Trade Plans - newser.com
Published on: 2025-10-12 22:17:07 - newser.com
Is NewAmsterdam Pharma Company NV a good long term investment - earlytimes.in
NewAmsterdam Pharma (NASDAQ:NAMS) Hits New 12-Month HighHere's Why - MarketBeat
NewAmsterdam Pharma (NAMS) Stock Soars on Cholesterol Drug Breakthrough – What Investors Should Know - ts2.tech
NAMS Stock Surge: What Lies Ahead? - timothysykes.com
NewAmsterdam Pharma (NASDAQ:NAMS) Given "Sell (D-)" Rating at Weiss Ratings - MarketBeat
Why NewAmsterdam Pharma (NAMS) Is Up 7.5% After Late-Stage Obicetrapib Trial Optimism - Yahoo Finance
NewAmsterdam Pharma Company N.V. Equity Warrant stock trend forecastMarket Sentiment Review & Weekly High Conviction Trade Ideas - newser.com
Published on: 2025-10-10 04:23:44 - newser.com
Exit strategy if you’re trapped in NewAmsterdam Pharma Company N.V. Equity WarrantEarnings Beat & Reliable Price Breakout Signals - newser.com
Is this a good reentry point in NewAmsterdam Pharma Company N.V.Weekly Stock Analysis & Smart Investment Allocation Insights - newser.com
Custom watchlist performance reports with NewAmsterdam Pharma Company N.V.Weekly Market Report & Daily Technical Forecast Reports - newser.com
NewAmsterdam Pharma Company N.V. stock momentum explainedTrend Reversal & AI Enhanced Execution Alerts - newser.com
Topper, director at NewAmsterdam Pharma, buys $31,487 in shares By Investing.com - Investing.com Nigeria
Knights of Columbus Asset Advisors LLC Invests $595,000 in NewAmsterdam Pharma Company N.V. $NAMS - MarketBeat
NewAmsterdam Pharma Hits New 52-Week High of $34.62 - Markets Mojo
NewAmsterdam Pharma Company N.V. (NAMS) Soars 5.9%: Is Further Upside Left in the Stock? - Nasdaq
Newamsterdam Pharma stock hits 52-week high at 31.96 USD By Investing.com - Investing.com Canada
NewAmsterdam Pharma (NASDAQ:NAMS) Stock Price Up 8.8%Here's Why - MarketBeat
NewAmsterdam Pharma Co. Hits New 52-Week High of USD 31.81 - Markets Mojo
Newamsterdam Pharma stock hits 52-week high at 31.96 USD - Investing.com
Will NewAmsterdam Pharma Company N.V. (KH6) stock beat Nasdaq index returnsQuarterly Earnings Summary & Target Return Focused Stock Picks - newser.com
Institutional scanner results for NewAmsterdam Pharma Company N.V.Portfolio Risk Report & Entry Point Confirmation Alerts - newser.com
How NewAmsterdam Pharma Company N.V. stock performs in weak economyWeekly Stock Summary & Smart Money Movement Alerts - newser.com
Published on: 2025-10-05 03:30:23 - newser.com
NewAmsterdam Pharma Company N.V. Equity Warrant stock retracement – recovery analysisStock Surge & Real-Time Market Sentiment Alerts - newser.com
NewAmsterdam Pharma Co. NV Hits New 52-Week High at $29.66 - Markets Mojo
Exit strategy if you’re trapped in NewAmsterdam Pharma Company N.V.July 2025 Setups & Verified Technical Signals - newser.com
Can you recover from losses in NewAmsterdam Pharma Company N.V.Quarterly Performance Summary & Daily Market Momentum Tracking - newser.com
How NewAmsterdam Pharma Company N.V. (KH6) stock moves on employment dataJuly 2025 Volume & Free Technical Confirmation Trade Alerts - newser.com
Published on: 2025-10-02 23:50:02 - newser.com
Using data tools to time your NewAmsterdam Pharma Company N.V. exitEarnings Growth Report & Risk Adjusted Buy/Sell Alerts - newser.com
Why NewAmsterdam Pharma Company N.V. Equity Warrant stock attracts global investorsTrade Signal Summary & Growth Oriented Trading Recommendations - newser.com
Is NewAmsterdam Pharma Company N.V. stock reversal real or fakeJuly 2025 Trends & Stock Portfolio Risk Management - newser.com
NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results - ADVFN
NewAmsterdam Pharma Provides Corporate Update and Reports Second Quarter Financial Results - ADVFN
NewAmsterdam Pharma (NASDAQ:NAMS) Reaches New 12-Month HighHere's What Happened - MarketBeat
Published on: 2025-10-01 08:11:23 - newser.com
NewAmsterdam Pharma Stock Hits Day High with 8.41% Surge - Markets Mojo
NewAmsterdam Pharma Soars 9.15% to Hit Intraday High of $26.75 - Markets Mojo
What drives NewAmsterdam Pharma Company NV Equity Warrant stock price - earlytimes.in
Newamsterdam Pharma Company Nv Stock (NAMS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Newamsterdam Pharma Company Nv Stock (NAMS) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Kooij Louise Frederika | Chief Accounting Officer |
Sep 09 '25 |
Option Exercise |
10.00 |
150,000 |
1,500,000 |
165,000 |
Kooij Louise Frederika | Chief Accounting Officer |
Sep 09 '25 |
Sale |
25.83 |
150,000 |
3,874,017 |
15,000 |
Topper James N | Director |
Sep 08 '25 |
Buy |
24.99 |
1,260 |
31,487 |
3,027,864 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):